Abstract
This Practice Point commentary discusses an observational study by Wahlgren et al. that examined the use of intravenous alteplase in a routine clinical setting 3–4.5 h after onset of stroke. The study recruited patients from the SITS-ISTR thrombolysis registry. The outcomes of 664 patients treated with intravenous alteplase at between 3 h and 4.5 h after stroke onset were compared with those of 11,865 patients treated within 3 h. No significant differences were noted between the two cohorts at 3 months regarding the rate of symptomatic intracerebral hemorrhage, mortality, or functional independence. The study provides invaluable information about the safety of alteplase for acute stroke when used within this extended time frame, although the investigation lacked comprehensive central auditing of the data, and it was difficult to ascertain whether all patients treated in the participating centers were included in the dataset and to verify that no biased reporting occurred.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581–1587
Wahlgren N et al. (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369: 275–282
Hacke W et al. (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317–1329
Kleindorfer D et al. (2008) National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39: 924–928
The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768–774
Wahlgren N et al. (2008) Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372: 1303–1309
Alberts MJ et al. (2005) Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 36: 1597–1616
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Leung, T., Wong, K. Thrombolysis with alteplase for acute ischemic stroke: safe and effective outside the 3-hour time window?. Nat Rev Neurol 5, 70–71 (2009). https://doi.org/10.1038/ncpneuro0993
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0993